Lista de obras -

(188)Re-HEDP combined with capecitabine in hormone-refractory prostate cancer patients with bone metastases: a phase I safety and toxicity study

artículo científico publicado en 2009

186Re-HEDP for metastatic bone pain in breast cancer patients

artículo científico publicado en 2004

Additional Heparin Preadministration Improves Cardiac Glucose Metabolism Suppression over Low-Carbohydrate Diet Alone in ¹⁸F-FDG PET Imaging

artículo científico publicado en 2015

Clinical and laboratory toxicity after intra-arterial radioembolization with (90)y-microspheres for unresectable liver metastases

artículo científico publicado en 2013

Combined use of zoledronic acid and 153Sm-EDTMP in hormone-refractory prostate cancer patients with bone metastases

artículo científico publicado en 2007

Delivery approaches of gene therapy in hepatocellular carcinoma

artículo científico publicado en 2013

Diagnostic Performance of ¹⁸F-FDG PET and PET/CT for the Detection of Recurrent Esophageal Cancer After Treatment with Curative Intent: A Systematic Review and Meta-Analysis.

artículo científico publicado en 2015

Fusion dual-tracer SPECT-based hepatic dosimetry predicts outcome after radioembolization for a wide range of tumour cell types

artículo científico publicado en 2015

Hepatic arterial configuration in relation to the segmental anatomy of the liver; observations on MDCT and DSA relevant to radioembolization treatment.

artículo científico publicado en 2014

Hepatic radioembolization as a bridge to liver surgery.

artículo científico publicado en 2014

Hepatobiliary scintigraphy may improve radioembolization treatment planning in HCC patients

artículo científico publicado en 2017

Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study ⬇️

artículo científico publicado el 22 de agosto de 2012

Holmium-166 radioembolization for the treatment of patients with liver metastases: design of the phase I HEPAR trial

artículo científico publicado en 2010

Identifying aberrant hepatic arteries prior to intra-arterial radioembolization.

artículo científico publicado en 2014

Innovation in catheter design for intra-arterial liver cancer treatments results in favorable particle-fluid dynamics.

artículo científico publicado en 2015

Intra-arterial radioembolization of breast cancer liver metastases: a structured review.

artículo científico publicado en 2013

Limitations of body surface area-based activity calculation for radioembolization of hepatic metastases in colorectal cancer.

artículo científico

Liver CT for vascular mapping during radioembolisation workup: comparison of an early and late arterial phase protocol.

artículo científico publicado en 2016

MRI-based biodistribution assessment of holmium-166 poly(L-lactic acid) microspheres after radioembolisation ⬇️

artículo científico publicado el 27 de septiembre de 2012

Management of High Hepatopulmonary Shunting in Patients Undergoing Hepatic Radioembolization

artículo científico publicado en 2015

Persistent disease in patients with papillary thyroid carcinoma and lymph node metastases after surgery and iodine-131 ablation.

artículo científico publicado en 2007

Quantification of aging effects upon global knee inflammation by 18F-FDG-PET.

artículo científico publicado en 2015

Quantitative 166Ho-microspheres SPECT derived from a dual-isotope acquisition with 99mTc-colloid is clinically feasible

scientific article published on 14 July 2020

Quantitative comparison of PET and Bremsstrahlung SPECT for imaging the in vivo yttrium-90 microsphere distribution after liver radioembolization

artículo científico publicado en 2013

Radiation emission from patients treated with holmium-166 radioembolization

artículo científico publicado en 2014

Radiation-induced cholecystitis after hepatic radioembolization: do we need to take precautionary measures?

artículo científico publicado en 2014

Radioembolization dosimetry: the road ahead

artículo científico

Radioembolization for treatment of salvage patients with colorectal cancer liver metastases: a systematic review

artículo científico publicado en 2013

Radioembolization-induced liver disease: a systematic review

artículo científico publicado en 2016

Radioembolization: Is Prophylactic Embolization of Hepaticoenteric Arteries Necessary? A Systematic Review

artículo científico publicado en 2016

Recommendations for radioembolisation after liver surgery using yttrium-90 resin microspheres based on a survey of an international expert panel.

artículo científico publicado en 2017

Root cause analysis of gastroduodenal ulceration after yttrium-90 radioembolization.

artículo científico

Safety of Repeated Yttrium-90 Radioembolization ⬇️

artículo científico publicado el 26 de enero de 2013

Splenomegaly-associated thrombocytopenia after hepatic yttrium-90 radioembolization

artículo científico publicado en 2013

Superselective Chemoembolization of HCC: Comparison of Short-term Safety and Efficacy between Drug-eluting LC Beads, QuadraSpheres, and Conventional Ethiodized Oil Emulsion

artículo científico publicado en 2015

Surefire infusion system versus standard microcatheter use during holmium-166 radioembolization: study protocol for a randomized controlled trial.

artículo científico publicado en 2016

The effect of intra-arterial angiotensin II on the hepatic tumor to non-tumor blood flow ratio for radioembolization: a systematic review.

artículo científico

The efficacy of hepatic 90Y resin radioembolization for metastatic neuroendocrine tumors: a meta-analysis.

artículo científico

The role of 90Y-radioembolization in downstaging primary and secondary hepatic malignancies: a systematic review

artículo científico publicado en 2016

Thoracic aorta calcification but not inflammation is associated with increased cardiovascular disease risk: results of the CAMONA study

artículo científico publicado en 2016

Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial

artículo científico publicado en 2012

Treatment of painful bone metastases in hormone-refractory prostate cancer with zoledronic acid and samarium-153-ethylenediaminetetramethylphosphonic acid combined

artículo científico publicado en 2009

Use of C-Arm Cone Beam CT During Hepatic Radioembolization: Protocol Optimization for Extrahepatic Shunting and Parenchymal Enhancement.

artículo científico publicado en 2015

[18F]Fluorodeoxyglucose PET for Interventional Oncology in Liver Malignancy

artículo científico

[18F]Fluorodeoxyglucose PET/Computed Tomography in Gastrointestinal Malignancies.

artículo científico

⁹⁰Y Hepatic Radioembolization: An Update on Current Practice and Recent Developments

artículo científico publicado en 2015

Lista de obras de

(188)Re-HEDP combined with capecitabine in hormone-refractory prostate cancer patients with bone metastases: a phase I safety and toxicity study

186Re-HEDP for metastatic bone pain in breast cancer patients

Additional Heparin Preadministration Improves Cardiac Glucose Metabolism Suppression over Low-Carbohydrate Diet Alone in ¹⁸F-FDG PET Imaging

Clinical and laboratory toxicity after intra-arterial radioembolization with (90)y-microspheres for unresectable liver metastases

Combined use of zoledronic acid and 153Sm-EDTMP in hormone-refractory prostate cancer patients with bone metastases

Delivery approaches of gene therapy in hepatocellular carcinoma

Diagnostic Performance of ¹⁸F-FDG PET and PET/CT for the Detection of Recurrent Esophageal Cancer After Treatment with Curative Intent: A Systematic Review and Meta-Analysis.

Fusion dual-tracer SPECT-based hepatic dosimetry predicts outcome after radioembolization for a wide range of tumour cell types

Hepatic arterial configuration in relation to the segmental anatomy of the liver; observations on MDCT and DSA relevant to radioembolization treatment.

Hepatic radioembolization as a bridge to liver surgery.

Hepatobiliary scintigraphy may improve radioembolization treatment planning in HCC patients

Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study ⬇️

Holmium-166 radioembolization for the treatment of patients with liver metastases: design of the phase I HEPAR trial

Identifying aberrant hepatic arteries prior to intra-arterial radioembolization.

Innovation in catheter design for intra-arterial liver cancer treatments results in favorable particle-fluid dynamics.

Intra-arterial radioembolization of breast cancer liver metastases: a structured review.

Limitations of body surface area-based activity calculation for radioembolization of hepatic metastases in colorectal cancer.

Liver CT for vascular mapping during radioembolisation workup: comparison of an early and late arterial phase protocol.

MRI-based biodistribution assessment of holmium-166 poly(L-lactic acid) microspheres after radioembolisation ⬇️

Management of High Hepatopulmonary Shunting in Patients Undergoing Hepatic Radioembolization

Persistent disease in patients with papillary thyroid carcinoma and lymph node metastases after surgery and iodine-131 ablation.

Quantification of aging effects upon global knee inflammation by 18F-FDG-PET.

Quantitative 166Ho-microspheres SPECT derived from a dual-isotope acquisition with 99mTc-colloid is clinically feasible

Quantitative comparison of PET and Bremsstrahlung SPECT for imaging the in vivo yttrium-90 microsphere distribution after liver radioembolization

Radiation emission from patients treated with holmium-166 radioembolization

Radiation-induced cholecystitis after hepatic radioembolization: do we need to take precautionary measures?

Radioembolization dosimetry: the road ahead

Radioembolization for treatment of salvage patients with colorectal cancer liver metastases: a systematic review

Radioembolization-induced liver disease: a systematic review

Radioembolization: Is Prophylactic Embolization of Hepaticoenteric Arteries Necessary? A Systematic Review

Recommendations for radioembolisation after liver surgery using yttrium-90 resin microspheres based on a survey of an international expert panel.

Root cause analysis of gastroduodenal ulceration after yttrium-90 radioembolization.

Safety of Repeated Yttrium-90 Radioembolization ⬇️

Splenomegaly-associated thrombocytopenia after hepatic yttrium-90 radioembolization

Superselective Chemoembolization of HCC: Comparison of Short-term Safety and Efficacy between Drug-eluting LC Beads, QuadraSpheres, and Conventional Ethiodized Oil Emulsion

Surefire infusion system versus standard microcatheter use during holmium-166 radioembolization: study protocol for a randomized controlled trial.

The effect of intra-arterial angiotensin II on the hepatic tumor to non-tumor blood flow ratio for radioembolization: a systematic review.

The efficacy of hepatic 90Y resin radioembolization for metastatic neuroendocrine tumors: a meta-analysis.

The role of 90Y-radioembolization in downstaging primary and secondary hepatic malignancies: a systematic review

Thoracic aorta calcification but not inflammation is associated with increased cardiovascular disease risk: results of the CAMONA study

Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial

Treatment of painful bone metastases in hormone-refractory prostate cancer with zoledronic acid and samarium-153-ethylenediaminetetramethylphosphonic acid combined

Use of C-Arm Cone Beam CT During Hepatic Radioembolization: Protocol Optimization for Extrahepatic Shunting and Parenchymal Enhancement.

[18F]Fluorodeoxyglucose PET for Interventional Oncology in Liver Malignancy

[18F]Fluorodeoxyglucose PET/Computed Tomography in Gastrointestinal Malignancies.

⁹⁰Y Hepatic Radioembolization: An Update on Current Practice and Recent Developments